Relief Therapeutics and NeuroRx have met the patient enrollment target of 165 agreed with the US Food and Drug Administration (FDA) in the trial of RLF-100 (aviptadil), a formulation of Vasoactive Intestinal Polypeptide (VIP) for Covid-19. The ongoing Phase IIb/III trial is evaluating RLF-100 for treating respiratory failure in critical Covid-19 patients. According to the […]

Until recently, Seattle boasted the fastest-growing economy in the United States, according to economic development agency Greater Seattle Partners. Today, obviously, that picture looks very different, as economic turbulence caused by the pandemic has created untold challenges. Nobody knows what next year will bring after a tumultuous and unprecedented 2020, but keep an eye on […]